CRP and rheumatoid arthritis: † Ethnicity analysis excluded Mixed White & Black patients due to low counts (n=3); ‡ Drug analysis compared baricitinib vs tofacitinib; upadacitinib and filgotinib were excluded due to small numbers (n=6 each); § DAS28-CRP analysis included RA patients.